Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Beyond cure: preventing and managing the complications of end-stage liver disease

Beyond cure: preventing and managing the complications of end-stage liver disease Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/01/2020 REVIEW URRENT Beyond cure: preventing and managing the PINION complications of end-stage liver disease a a b Marina Berenguer , Marı´a Garcı´a-Eliz , Chiara Baiguera , and Massimo Puoti Purpose of review The aim of this review was to define the implication of hepatitis C virus (HCV) eradication in patients with cirrhosis. Recent findings Sustained virologic response (SVR) is associated with a favourable outcome in patients with cirrhosis especially in the presence of regression of cirrhosis but also with extrahepatic outcomes regarding health- related quality of life, risk of diabetes, risk of cardiovascular diseases and control of HIV replication by antiretroviral therapy. In patients with decompensated cirrhosis identifying the point of no return where viral eradication is not followed by clinical improvement is extremely relevant. A strict follow-up is needed in order to early diagnose HCC and signs of liver dysfunction, even after SVR, not only in patients with histological diagnosis of cirrhosis but also in those with advanced disease identified by liver stiffness measurements or by noninvasive methods. Summary Eradication of HCV is associated with regression or ‘freezing’ of cirrhosis even if it is still unknown the point of no return http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV & AIDS Wolters Kluwer Health

Beyond cure: preventing and managing the complications of end-stage liver disease

Download PDF
6 pages

Loading next page...
 
/lp/wolters-kluwer-health/beyond-cure-preventing-and-managing-the-complications-of-end-stage-05ZzcHeC9v

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/COH.0000000000000184
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/01/2020 REVIEW URRENT Beyond cure: preventing and managing the PINION complications of end-stage liver disease a a b Marina Berenguer , Marı´a Garcı´a-Eliz , Chiara Baiguera , and Massimo Puoti Purpose of review The aim of this review was to define the implication of hepatitis C virus (HCV) eradication in patients with cirrhosis. Recent findings Sustained virologic response (SVR) is associated with a favourable outcome in patients with cirrhosis especially in the presence of regression of cirrhosis but also with extrahepatic outcomes regarding health- related quality of life, risk of diabetes, risk of cardiovascular diseases and control of HIV replication by antiretroviral therapy. In patients with decompensated cirrhosis identifying the point of no return where viral eradication is not followed by clinical improvement is extremely relevant. A strict follow-up is needed in order to early diagnose HCC and signs of liver dysfunction, even after SVR, not only in patients with histological diagnosis of cirrhosis but also in those with advanced disease identified by liver stiffness measurements or by noninvasive methods. Summary Eradication of HCV is associated with regression or ‘freezing’ of cirrhosis even if it is still unknown the point of no return

Journal

Current Opinion in HIV & AIDS – Wolters Kluwer Health

Published: Sep 1, 2015

There are no references for this article.